A. Cipri

Locally advanced non-small cell lung cancer: role of induction chemotherapy in resectable N2 disease.

F. de Marinis, S. De Santis, L. de Petris, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Original article A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomized trial

G. Scagliotti, C. Gridelli, M. Rinaldi, 2005 .

Cisplatin (P), etoposide (E) and gemcitabine (G), in untreated patients with small cell lung cancer (SCLC): Preliminary results of a multi-institutional phase II trial

E. Cortesi, S. Ramponi, F. Marinis, 2000 .

A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.

G. Scagliotti, C. Gridelli, M. Rinaldi, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

803 Ciprofloxacin and G-CSF for fever treatment in neutropenic outpatients with advanced non small cell lung cancer (NSCLC), treated with chemotherapy (CT)

R. Gareri, M. Noseda, F. Marinis, 1997 .

Inorganic particles in bronchoalveolar lavage fluids from nonoccupationally exposed subjects.

M. Falchi, C. Conti, L. Paoletti, 1996, Archives of environmental health.

Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer.

F. de Marinis, E. Cortesi, S. Gasperoni, 2003, Lung cancer.